immunization and vaccine development (ivd) searo · immunization and vaccine development (ivd)...

23
Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable Disease and Immunization Update Published: October 07, 2015

Upload: leanh

Post on 11-Nov-2018

236 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

Immunization and Vaccine

Development (IVD) SEARO

Protecting People from Vaccine Preventable Diseases

Monthly Vaccine Preventable Disease and

Immunization Update

Published: October 07, 2015

Page 2: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

Last wild poliovirus case by type, SEAR

*Dots are randomly placed within blocks (Sub-districts)

WPV Type 2

District: Aligarh

State: Uttar Pradesh (India)

Date of onset: 24-Oct-1999

WPV Type 3

District: Pakur

State: Jharkhand (India)

Date of onset: 22-Oct-2010

WPV Type 1

District: Howrah

State: West Bengal (India)

Date of onset: 13-Jan-2011

Country Year

Bangladesh 2006

Bhutan 1986

DPR Korea 1996

India 2011

Indonesia 2006

Maldives 1994

Myanmar 2007

Nepal 2010

Sri Lanka 1993

Thailand 1997

Timor-Leste 1995

Last wild poliovirus

case by country

Data as of 05 Oct 2015

Page 3: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

% Adequate Stool Specimen Collection Non-polio AFP Rate

The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of

the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation

of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

© WHO 2015. All rights reserved

< 1

1 – 1.99

>2

No Non-Polio AFP Case

< 60%

60% – 79%

> 80%

No AFP Case

AFP Surveillance Indicators by First Administrative Level*, 2015

Total AFP Cases = 36187

Non-Polio AFP Rate =7.02

Adequate Stool specimen = 86%

Countries reporting AFP cases= 10 (91%)

*Bhutan, Maldives & Timor-Leste by country

Data as of 05 Oct 2015

Page 4: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

4

Non-polio AFP Cases by Month of Onset

SEAR, 2011-2015 Month 2011 2012 2013 2014 2015

Jan 4598 4994 4560 4451 4118

Feb 3863 4483 4016 3990 3751

Mar 4344 4586 4279 4185 3674

Apr 4302 4727 4305 4018 3494

May 4874 5486 4430 4500 3696

Jun 5387 5449 5035 5149 3901

Jul 6175 5959 5832 5518 3754

Aug 7000 7564 5940 6414 4287

Sep 7308 7888 6034 6122 1368

Oct 6255 5709 5282 5086

Nov 5793 4785 5171 4952

Dec 5370 4382 4534 4095

Total 65269 66012 59418 58480 32043

Data as of 05 Oct 2015

Page 5: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

5

0

0.5

1

1.5

2

2.5

3

3.5

4

4.5

5

5.5

6

BAN BHU DPRK IND INO MAV MMR NEP SRL THA TLS

No

n-P

olio

AF

P R

ate

2011 2012 2013 2014 2015

Non-polio AFP Rate*

SEAR, 2011–2015

* Number of discarded AFP cases per 100,000 children under 15 years of age

SEAR Minimum Target

and above ~~~~~~~~

9.02

13.49 13.94

12.48 6.12

12.50

Data as of 05 Oct 2015

Page 6: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

6

Percent Adequate Stool Specimen Collection*

SEAR, 2011-2015

0

20

40

60

80

100

BAN BHU DPRK IND INO MAV MMR NEP SRL THA TLS

2011 2012 2013 2014 2015

Minimum Target

Perc

en

t

*Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Data as of 05 Oct 2015

Page 7: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

7

N=

794

N=

838

N=

30571

N=

964

N=

145

N=

291

N=

76

N=

909

N=

35175

N=

931

N=

170

N=

277

N=

103

Percent of Non-Polio AFP Cases Under Immunized for OPV

(6 Months to 5 Yrs), SEAR, 2011-2015

N=

862

N=

33691

N=

987

N=

164

N=

303

N=

100

N=

28997

N=

898

N=

158

N=

236

N=

80

N=

617

N=

16277

N=

339

N=

62

N=

138

N=

46

Data as of 05 Oct 2015

Page 8: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

8

Total AFP Cases = 33574

Non-Polio AFP Rate =9.02

Adequate Stool specimen = 85%

Districts reporting AFP cases= 628 (93%)

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case

Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

Data as of 05 Oct 2015

AFP Surveillance Indicators by District

India, 2015

Non-polio AFP Rate* Percent Adequate Stool

Specimen Collection **

Page 9: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

9

Non-polio AFP Cases by Month of Onset

India, 2011-2015 Month 2011 2012 2013 2014 2015

Jan 4241 4599 4132 4110 3799

Feb 3538 4113 3644 3657 3493

Mar 3983 4170 3885 3781 3339

Apr 3926 4262 3864 3621 3223

May 4462 5001 4007 4042 3376

Jun 4978 4988 4622 4683 3584

Jul 5692 5452 5385 5168 3531

Aug 6582 7119 5555 6035 4010

Sep 6852 7386 5590 5747 1322

Oct 5800 5282 4888 4711

Nov 5400 4455 4777 4565

Dec 5024 4063 4245 3790

Total 60478 60890 54594 53910 29677

Data as of 05 Oct 2015

Page 10: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

10

AFP Surveillance Indicators by District

Nepal, 2015

Total AFP Cases = 282

Non-Polio AFP Rate = 3.48

Adequate Stool specimen = 95%

Districts reporting AFP cases= 68(91%)

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Non-polio AFP Rate* Percent Adequate Stool

Specimen Collection **

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case

Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

Data as of 05 Oct 2015

Page 11: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

11

Non-polio AFP Cases by Month of Onset

Nepal, 2011-2015 Month 2011 2012 2013 2014 2015

Jan 43 50 32 50 32

Feb 21 51 41 48 30

Mar 42 47 61 40 46

Apr 46 51 56 31 25

May 49 61 49 41 19

Jun 44 69 57 42 37

Jul 59 70 65 47 36

Aug 64 92 63 38 37

Sep 63 69 47 40 5

Oct 43 37 30 37

Nov 48 22 37 38

Dec 46 21 38 34

Total 568 640 576 486 267

Data as of 05 Oct 2015

Page 12: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

12

AFP Surveillance Indicators by Province

Myanmar, 2015

Total AFP Cases = 195

Non-Polio AFP Rate =1.58

Adequate Stool specimen = 93%

Provinces reporting AFP cases= 17 (94%)

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Non-polio AFP Rate* Percent Adequate Stool

Specimen Collection **

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

Data as of 05 Oct 2015

Page 13: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

13

Non-polio AFP Cases by Month of Onset

Myanmar, 2011-2015

Month 2011 2012 2013 2014 2015

Jan 27 18 32 41 21

Feb 29 9 13 24 19

Mar 24 11 16 19 16

Apr 21 22 20 22 14

May 33 35 18 38 27

Jun 36 42 27 38 18

Jul 41 44 34 39 26

Aug 39 58 36 47 27

Sep 53 96 27 42 2

Oct 52 64 49 29

Nov 38 33 63 24

Dec 25 24 69 26

Total 418 456 404 389 170

Data as of 05 Oct 2015

Page 14: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

14

AFP Surveillance Indicators by District

Bangladesh, 2015

Total AFP Cases = 1071

Non-Polio AFP Rate =2.63

Adequate Stool specimen = 97%

Districts reporting AFP cases= 64 (100%)

Non-polio AFP Rate* Percent Adequate Stool Specimen

Collection **

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case

Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Data as of 05 Oct 2015

Page 15: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

15

Non-polio AFP Cases by Month of Onset

Bangladesh, 2011-2015 Month 2011 2012 2013 2014 2015

Jan 130 122 155 73 87

Feb 109 112 110 69 100

Mar 105 135 107 115 126

Apr 127 168 125 130 121

May 155 140 148 169 167

Jun 151 145 149 198 134

Jul 183 146 134 154 105

Aug 159 114 116 168 138

Sep 154 153 125 117 31

Oct 142 128 95 102

Nov 92 120 94 104

Dec 103 84 54 79

Total 1610 1567 1412 1478 1009

Data as of 05 Oct 2015

Page 16: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

16

AFP Surveillance Indicators by Province

Indonesia, 2015

Total AFP Cases = 802

Non-Polio AFP Rate = 1.35

Adequate Stool specimen = 94%

Provinces reporting AFP cases= 31 (91%)

Non-polio AFP Rate*

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Percent Adequate Stool Specimen Collection **

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case

Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

Data as of 05 Oct 2015

Page 17: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

17

Non-polio AFP Cases by Month of Onset

Indonesia, 2011-2015 Month 2011 2012 2013 2014 2015

Jan 118 164 169 135 142

Feb 125 160 181 149 96

Mar 160 174 174 198 111

Apr 153 200 195 184 92

May 130 203 163 172 79

Jun 140 164 144 155 91

Jul 160 200 166 66 36

Aug 114 129 131 87 58

Sep 137 139 205 158 6

Oct 178 147 182 165

Nov 171 114 158 170

Dec 134 157 94 125

Total 1720 1951 1962 1764 711

Data as of 05 Oct 2015

Page 18: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

18

AFP Surveillance Indicators by Province

Thailand, 2015

Total AFP Cases = 116

Non-Polio AFP Rate = 1.05

Adequate Stool specimen = 69%

Provinces reporting AFP cases= 57 (74%)

Annualized Non-polio AFP Rate*

* Number of discarded AFP cases per 100,000 children under 15 years of age (annualized by week 40, 2015)

** Percentage with 2 specimens 24 hours apart and within 14 days of paralysis onset.

Note: Some AFP cases may still be pending final classification.

Percent Adequate Stool Specimen Collection **

Adequate Stool

Specimen Collection

< 60%

60% – 79%

> 80%

No AFP Case

Non-Polio AFP Rate

< 1

1 – 1.99

>2

No Non-Polio AFP Case

Data as of 05 Oct 2015

Page 19: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

19

Non-polio AFP Cases by Month of Onset

Thailand, 2010-2014 Month 2011 2012 2013 2014 2015

Jan 17 22 19 24 14

Feb 18 24 20 25 5

Mar 13 25 24 12 11

Apr 13 7 22 16 13

May 26 20 19 17 15

Jun 17 15 17 18 15

Jul 26 30 27 27 13

Aug 22 30 19 18 9

Sep 24 30 18 11 1

Oct 27 37 16 19

Nov 22 27 18 25

Dec 24 22 16 26

Total 249 289 235 238 96

Data as of 05 Oct 2015

Page 20: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

VPD Reporting, 2014

Data as of 31 May 2015

# O

utb

rea

ks

# C

ase

s

# O

utb

rea

ks

# C

ase

s

# O

utb

rea

ks

# C

ase

s

Bangladesh 1668 0 1607 97 176 71 71 1368 0 9 178 11 166 2 31 105 13 12 NR 3490 15-Apr-15 12 100 100

Bhutan 69 0 69 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 35 18 18-Mar-15 12 75 75

DPR Korea 11 0 11 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13-Mar-14 12 8 8

India 54193 110 NR NR NR 1693 1013 34818 101 768 26113 110 4993 17 614 NR NR NR NR NR 19-Jun-15 12 8 0

Indonesia 12943 7 5719 1471 713 173 108 2104 21 80 803 7 69 3 13 75 421 NR NR NR 20-Apr-15 12 83 17

Maldives 0 0 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 15-Jan-15 12 42 25

Myanmar 242 0 242 8 24 7 7 236 0 3 102 1 5 0 0 32 35 3 0 34 20-Mar-15 12 83 75

Nepal 350 1 292 9 14 2 2 18 0 0 0 0 0 0 0 7 NR NR 1423 19 12-Feb-15 12 100 75

Sri Lanka 3117 0 2123 1560 10 1 1 10 0 0 0 1 10 0 0 0 0 81 191 6957 17-Mar-15 12 100 100

Thailand 1191 0 427 70 19 0 0 0 0 0 0 0 0 0 0 2 17 14 589 NR 22-Jan-15 12 83 25

Timor-Leste 47 1 40 25 1 2 2 33 1 2 20 0 0 0 0 1 2 3 6 3 23-Jan-15 12 8 0

Total 73831 119 10539 3240 961 1949 1204 38587 123 862 27216 130 5243 22 658 222 488 113 2244 105241 At least 5 blood samples should be collected and tested from each outbreak. 2 Adverse Events Follow ing Immunization; Sri Lanka AEFI data do not reflect cases but events. 3 Monthly VPD and AEFI reports due to SEARO/IVD on or before 15th of each month. NR=No report

Date

of

last

rep

ort

# r

ep

ort

s e

xp

ecte

d

% C

om

ple

ten

ess

% T

imeli

ness

Neonata

l T

eta

nus

Dip

hth

eria

Pert

ussis

Encephalitis

Nu

mb

er

of

Cases o

f

AE

FI

2

Number of Cases

Country

Routine Reporting of clinically

suspected measles cases

Suspected measles

outbreaksLaboratory Confirmed1

# R

ub

ella

+ve

# O

utb

rea

ks

# O

utb

rea

ks

Inve

stig

ate

d

# C

ase

s

# D

ea

ths

Rubella

Outbreaks

Mixed

Outbreaks

# C

ase

s

# D

ea

ths

# T

este

d fo

r

se

rolo

gy

# M

ea

sle

s +

ve

Measles

Outbreaks

Page 21: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

VPD Reporting, 2015

Data as of 31 August 2015

# O

utb

rea

ks

# C

ase

s

# O

utb

rea

ks

# C

ase

s

# O

utb

rea

ks

# C

ase

s

Bangladesh 1703 0 1663 97 85 55 55 763 0 4 54 3 48 2 5 57 0 9 0 1501 15-Sep-15 8 100 100

Bhutan 51 0 51 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 5 12-Sep-15 8 63 63

DPR Korea 91 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19-Aug-15 8 13 0

India 47598 156 NR NR NR 1745 890 21271 105 586 14682 75 2194 26 599 NR NR NR NR NR 21-Sep-15 8 50 13

Indonesia 4884 6 2426 400 390 37 6 511 0 12 115 5 96 1 4 37 228 31 413 NR 28-Sep-15 8 100 13

Maldives 9 0 9 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 08-Jun-15 8 50 25

Myanmar 165 0 165 2 26 0 0 0 0 0 0 0 0 0 0 15 55 2 0 143 18-Sep-15 8 100 75

Nepal 178 3 145 21 5 8 8 137 1 5 44 0 0 0 0 4 NR NR 396 1 15-Sep-15 8 100 88

Sri Lanka 1821 0 1364 1040 7 1 1 53 0 1 53 0 0 0 0 0 0 63 103 6295 15-Sep-15 8 100 100

Thailand 381 0 381 18 29 6 6 55 0 9 9 2 35 0 0 0 12 31 437 NR 28-Sep-15 8 50 25

Timor-Leste 42 0 28 6 4 0 0 0 0 0 0 0 0 0 0 1 1 3 2 1 21-Sep-15 8 25 0

Total 56923 165 6232 1585 548 1852 966 22790 106 617 14957 85 2373 29 608 114 296 140 1351 79461 At least 5 blood samples should be collected and tested from each outbreak. 2 Adverse Events Follow ing Immunization; Sri Lanka AEFI data do not reflect cases but events. 3 Monthly VPD and AEFI reports due to SEARO/IVD on or before 15th of each month. NR=No report

# O

utb

rea

ks

Country

Routine Reporting of clinically

suspected measles cases

Suspected measles

outbreaksLaboratory Confirmed1

# O

utb

rea

ks

Inve

stig

ate

d

# C

ase

s

# D

ea

ths

Measles

Outbreaks

# C

ase

s

# D

ea

ths

# T

este

d fo

r

se

rolo

gy

# M

ea

sle

s +

ve

# R

ub

ella

+ve

Rubella

Outbreaks

Mixed

Outbreaks

Neonata

l T

eta

nus

Dip

hth

eria

Pert

ussis

Encephalit

is

Date

of

last

rep

ort

# r

ep

ort

s e

xp

ecte

d

% C

om

ple

ten

ess

% T

imeli

ness

Number of Cases

Nu

mb

er

of

Cases o

f

AE

FI

2

Page 22: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

Measles and Rubella Serology (IgM), 2014

Data as of 31 January 2015

# % # %

Bangladesh Dhaka 2051 1992 143 7.2 221 12.0 99.6

Bhutan Thimphu 69 61 0 0.0 4 6.6 77.0

DPR Korea Pyongyang 55 55 2 3.6 0 0.0 100.0

Ahmedabad 468 468 306 65.4 25 15.4 99.6

Bengaluru 528 381 258 67.7 27 22.0 93.7

Bhopal 212 212 134 63.2 21 26.9 63.7

Chennai 796 263 150 57.0 20 17.7 86.7

Guw ahati 74 74 28 37.8 32 69.6 95.9

Hyderabad 138 138 103 74.6 3 8.6 95.7

Jaipur 289 289 205 70.9 17 20.2 95.2

Kolkata 1386 1386 752 54.3 281 44.3 0.0

Lucknow 683 623 496 79.6 15 11.8 62.8

Patna 171 171 117 68.4 11 20.4 66.7

Pune 889 869 570 65.6 38 12.7 91.6

5634 4874 3119 64.0 490 27.9 60.8

Bandung 902 902 369 40.9 231 43.3 96.1

Jakarta 4083 4027 1558 38.7 531 21.5 65.7

Surabaya 2860 2857 1718 60.1 189 16.6 44.5

Yogyakarta 2643 2643 661 25.0 394 19.9 58.3

10488 10429 4306 41.3 1345 22.0 60.6

Maldives Male 695 695 0 0.0 3 0.4 100.0

Myanmar Yangon 282 282 24 8.5 29 11.2 83.3

Nepal Kathmandu 328 328 8 2.4 15 4.7 97.3

Sri Lanka Colombo 2080 2054 1496 72.8 10 1.8 86.8

Thailand Bangkok 147 147 12 8.2 8 5.9 100.0

Timor-Leste Dilli NR NR NR NR NR NR NR

21829 20917 9110 43.6 2125 18.0 69.6

Source: Reported by SEAR Measles Laboratory Netw ork NR=No Report

1 To be reported w ithin 4 days in 2014 - in transition state

Indonesia Total

TOTAL

Measles +ve Rubella +ve

India

India Total

Indonesia

Country LaboratoriesNumber of Serum

Samples ReceivedNumber Tested

Results

% Results Reported within 7

Days 1

Page 23: Immunization and Vaccine Development (IVD) SEARO · Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Monthly Vaccine Preventable

Measles and Rubella Serology (IgM), 2015

Data as of 31 August 2015

# % # %

Bangladesh Dhaka 1972 1972 122 6.2 104 5.6 90.5

Bhutan Thimphu 51 51 1 2.0 0 0.0 100.0

DPR Korea Pyongyang NR NR NR NR NR NR NR

Ahmedabad 385 385 258 67.0 48 37.8 99.7

Bengaluru 436 364 142 39.0 111 50.0 100.0

Bhopal 213 213 165 77.5 11 22.9 96.2

Chandigarh 116 115 83 72.2 15 46.9 93.0

Chennai 648 169 106 62.7 22 34.9 92.3

Delhi 369 366 245 66.9 23 19.0 74.6

Guw ahati 240 181 136 75.1 11 24.4 97.2

Hyderabad 48 48 24 50.0 12 50.0 100.0

Jaipur 364 364 255 70.1 25 22.9 98.1

Kolkata 1028 1028 598 58.2 189 44.0 53.4

Lucknow 2110 1886 1331 70.6 90 16.2 65.9

Patna 514 509 329 64.6 30 16.7 84.5

Pune 517 433 277 64.0 36 23.1 88.2

6988 6061 3949 65.2 623 29.5 77.1

Bandung 975 916 279 30.5 383 60.1 89.4

Jakarta 2753 2178 574 26.4 472 29.4 74.5

Surabaya 1520 1275 487 38.2 183 23.2 63.8

Yogyakarta 1654 1452 143 9.8 415 31.7 79.1

6902 5821 1483 25.5 1453 33.5 75.6

Maldives Male 9 9 0 0.0 2 22.2 100.0

Myanmar Yangon 165 165 2 1.2 26 16.0 93.9

Nepal Kathmandu 329 329 80 24.3 14 5.6 99.1

Sri Lanka Colombo 1728 1364 1040 76.2 7 2.2 90.7

Thailand Bangkok 141 140 2 1.4 14 10.1 100.0

Timor-Leste Dilli NR NR NR NR NR NR NR

18285 15912 6679 42.0 2243 24.3 80.3

Source: Reported by SEAR Measles Laboratory Netw ork NR=No Report

1 To be reported w ithin 4 days from 2014 - in transition state

Indonesia

Indonesia Total

TOTAL

Measles +ve Rubella +ve

India

India Total

Country LaboratoriesNumber of Serum

Samples ReceivedNumber Tested

Results

% Measles Results

Reported within 4 Days 1